Grantopen🌐 United StatesPAR-25-153

Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)

National Institutes of Health

Details?

Posted: Nov 6, 2024
Response deadline: Sep 7, 2026, 12:00 AM UTC (57d)
Type: Grant
Category: 93.395
Status: open
Buyer: National Institutes of Health
Department: HHS-NIH11
Jurisdiction: United States
Reference #: PAR-25-153

Doc Type: synopsis
Opp Status: posted

Similar open solicitations

Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)
United States · Dec 13, 2024
Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
United States · Nov 14, 2024
Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed)
United States · May 4, 2026
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
United States · Oct 10, 2024
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
United States · Oct 22, 2024
Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)
United States · Nov 15, 2024

Similar past solicitations

Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed)
United States · Nov 6, 2024
Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed)
United States · Nov 21, 2024
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)
United States · Nov 6, 2024
Dynamic and Adaptable Infrastructure for Drug Development and Outreach to Aid the Research Community in Advancing Medication Repurposing and Repositioning Efforts for Substance Use Disorders (SUDs) (U54 - Clinical Trials Not Allowed)
United States · Sep 24, 2025
Partnerships for Development of Vaccines to Prevent Mycobacterium tuberculosis Infection and/or Disease (R01 Clinical Trial Not Allowed)
United States · Aug 26, 2025

Finding similar opportunities…

This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.